INS and type 2 diabetes mellitus: Therefore, DCAs were implied that it can be a useful alternative substrate in parenteral nutrition, sparing glucose utilization and increasing glycogen stores in those clinical conditions like type 2 diabetes, where reduced insulin‐induced glucose uptake and oxidation are observed.